US2021023102A1PendingUtilityA1
Compositions for use in improving stool consistency or frequency in infants or young children
Est. expiryMar 5, 2035(~8.6 yrs left)· nominal 20-yr term from priority
A61P 1/06A23L 33/21A23L 33/135A61K 9/0056A61P 1/00A61K 2035/115A23V 2002/00A23L 33/40A61K 35/741A61K 31/702A23L 33/125A23L 33/10A23V 2400/21A23V 2400/11A23V 2400/51
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a nutritional composition comprising at least one fucosylated oligosaccharide for use in preventing and/or treating constipation and/or in improving stool consistency/frequency in an infant or a young child.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method of treating colics in an infant or a young child in need thereof, the method comprising administering a nutritional composition to the infant or young child, the nutritional composition comprising at least one fucosylated oligosaccharide, and wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100 g of composition on a dry weight basis.
3 . The method according to claim 2 wherein the fucosylated oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3′ fucosyllactose, difucosyllactose, lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-fucohexaose, lacto-N-difucohexaose I, fucosyllacto-N-hexaose, fucosyllacto-N-neohexaose I, fucosyllacto-N-neohexaose II, difucosyllacto-N-hexaose I, difucosyllacto-N-neohexaose I, difucosyllacto-N-neohexaose II, fucosyl-para-Lacto-N-hexaose, and any combination thereof.
4 . The method according to claim 2 , wherein the fucosylated oligosaccharide comprises a 2′ fucosyl-epitope.
5 . The method according to claim 2 , wherein the fucosylated oligosaccharide is 2′-fucosyllactose (2′FL).
6 . The method according to claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.2-3 g/L of the composition and/or in a total amount of 0.13-2.1 g/100 g of composition on a dry weight basis.
7 . The method according to claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 0.8-1.5 g/L of the composition and/or in a total amount of 0.55-1.05 g/100 g of composition on a dry weight basis.
8 . The method according to claim 2 , wherein the fucosylated oligosaccharide(s) is/are in a total amount of 1-1.25 g/L of the composition and/or in a total amount of 0.69-0.87 g/100 g of composition on a dry weight basis.
9 . (canceled)
10 . The method according to claim 2 , wherein the composition further comprising at least one probiotic microorganism.
11 - 13 . (canceled)
14 . The method according to claim 2 , wherein the nutritional composition is in a form selected from the group consisting of an infant formula, a starter infant formula, a follow-on or follow-up infant formula, a baby food, an infant cereal composition, a fortifier and a supplement.
15 . (canceled)
16 . The method according to claim 2 , wherein the composition does not comprise any N-acetylated oligosaccharides.
17 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.